These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2407779)
1. Poliomyelitis vaccines. Success and controversy. LaForce FM Infect Dis Clin North Am; 1990 Mar; 4(1):75-83. PubMed ID: 2407779 [TBL] [Abstract][Full Text] [Related]
2. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
3. [Worldwide eradication of poliomyelitis]. Rasch G; Schreier E; Kiehl W; Kurth R Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120 [TBL] [Abstract][Full Text] [Related]
4. Paralytic poliomyelitis--United States, 1980-1994. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844 [TBL] [Abstract][Full Text] [Related]
11. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?]. Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843 [TBL] [Abstract][Full Text] [Related]
13. [Advantages and disadvantages of antipoliomyelitis vaccines prepared with live and killed viruses]. Melnick JL Bol Oficina Sanit Panam; 1980 Jun; 88(6):507-29. PubMed ID: 6448065 [No Abstract] [Full Text] [Related]
14. Vaccine-associated poliomyelitis cases. Sabin AB Bull World Health Organ; 1969; 40(6):947-9. PubMed ID: 5307605 [No Abstract] [Full Text] [Related]
15. Risk management in a polio-free world. Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391 [TBL] [Abstract][Full Text] [Related]
16. Toward eradication of poliomyelitis by combined use of killed and live vaccines. Melnick JL Cardiovasc Res Cent Bull; 1982; 20(3):49-60. PubMed ID: 6805957 [No Abstract] [Full Text] [Related]
17. Polio eradication: the OPV paradox. Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339 [TBL] [Abstract][Full Text] [Related]
18. Poliomyelitis vaccines: killed or live? Br Med J; 1978 Sep; 2(6141):845-6. PubMed ID: 709087 [No Abstract] [Full Text] [Related]
19. A developing country perspective on vaccine-associated paralytic poliomyelitis. John TJ Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301 [TBL] [Abstract][Full Text] [Related]
20. Apropos risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Arya SC; Agarwal N Expert Rev Vaccines; 2012 Nov; 11(11):1291. PubMed ID: 23249227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]